Up on bad news and high volume , who knows what we don't
Its the volume that makes this interesting. The volume of shares traded on Friday was certainly not from all the brainiacs reading this post. Obviously institutional buying , throw in some short covering and who knows what else. What do they know that the rest of us don't. This company is obviously not about selling drugs. Its all about drug development and discovery. Even with its inept management they will eventually stumble on to a cure or partial cure for something and lets face it, there are thousands of illnesses that need curing. They do have a large pipeline and this is where all the value lies. Certainly not with its so called colesteral drug. They continue to partner up with some very large heavyweights so who knows. Keeping things a secret with regards to any takeover will be next to impossible. It could very well happen and one thing I am 100% sure of .... If it happens it will be a lawyers wet dream. I'm holding because this is now getting very interesting !!